mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.036 |
0.8 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.8 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |